Literature DB >> 452942

Mortality and morbidity during 13.5 years' follow-up in relation to blood pressure. The study of men born in 1913.

K Svärdsudd, G Tibblin.   

Abstract

A total of 973 50-year-old men, randomly selected from the general population in Göteborg, Sweden, were invited to a survey in 1963. Altogether 855 men (88%) participated. They have been followed up for 13.5 years, and this report presents mortality and morbidity during this time in relation to BP at the time of the initial examination. BP was strongly associated with mortality regardless of its cause. This was due to a close relation of BP to mortality from ischaemic heart disease and a weak but significant relation to mortality from cancer. BP was also strongly related to morbidity from myocardial infarction, stroke and angina pectoris, showed a tendency towards relation to morbidity from intermittent claudication and kidney stone, and was negatively related to morbidity from neoplasm for survivors. BP was also related to pension but not to sick leave. There is no indication of a decreasing importance of BP as a risk factor in this age period.

Entities:  

Mesh:

Year:  1979        PMID: 452942     DOI: 10.1111/j.0954-6820.1979.tb06089.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  7 in total

1.  Cost effectiveness and equity of a community based cardiovascular disease prevention programme in Norsjö, Sweden.

Authors:  L Lindholm; M Rosén; L Weinehall; K Asplund
Journal:  J Epidemiol Community Health       Date:  1996-04       Impact factor: 3.710

2.  Factors determining case fatality in myocardial infarction "who dies in a heart attack"?

Authors:  G Wannamethee; P H Whincup; A G Shaper; M Walker; P W MacFarlane
Journal:  Br Heart J       Date:  1995-09

Review 3.  ACE inhibitors in elderly patients with hypertension. Special considerations.

Authors:  M Ravid; D Ravid
Journal:  Drugs Aging       Date:  1996-01       Impact factor: 3.923

4.  Hypertensive nephropathy and cancer: Is it the hypertension, the nephropathy, or both?

Authors:  Sabine Karam
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-05-24       Impact factor: 3.738

Review 5.  Antihypertensive therapy and cancer risk.

Authors:  D C Felmeden; G Y Lip
Journal:  Drug Saf       Date:  2001       Impact factor: 5.228

6.  Influence of Hypertension on the Survival of Non-Small Cell Lung Cancer Patients with Type 2 Diabetes Mellitus.

Authors:  Xianghua Zeng; Dong Zeng; Jianan Cheng; Cheng Xu; Chengdu Sun; Haixia Long; Bo Zhu
Journal:  Med Sci Monit       Date:  2020-04-19

7.  Blood pressure and site-specific cancer mortality: evidence from the original Whitehall study.

Authors:  G D Batty; M J Shipley; M G Marmot; G Davey Smith
Journal:  Br J Cancer       Date:  2003-10-06       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.